Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India

BACKGROUND: In the west, survival following treatment of childhood acute lymphoblastic leukaemia (ALL) approaches 90%. Outcomes in India do not exceed 70%. To address this disparity, the Indian Collaborative Childhood Leukaemia group (ICiCLe) developed in 2013 a contemporary treatment protocol for u...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Nandana, Banavali, Shripad, Bakhshi, Sameer, Trehan, Amita, Radhakrishnan, Venkatraman, Seth, Rachna, Arora, Brijesh, Narula, Gaurav, Sinha, Subir, Roy, Prakriti, Gogoi, Manash Pratim, Chatterjee, Sayan, Abraham, Bindhu, Das, Parag, Saha, Vaskar, Krishnan, Shekhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805436/
https://www.ncbi.nlm.nih.gov/pubmed/35101099
http://dx.doi.org/10.1186/s13063-022-06033-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805436/
https://www.ncbi.nlm.nih.gov/pubmed/35101099
http://dx.doi.org/10.1186/s13063-022-06033-1

Ejemplares similares